- Poster presentation
- Open Access
Skin-testing protocol in diagnosing of the IgE-mediated peanut allergy
© Behroo et al; licensee BioMed Central Ltd. 2015
Published: 30 March 2015
In the event that a food-allergen was presumed as a likely accused of signs/symptoms, after that, the substantiation of major associations and finally, identifying the incriminated food(s) need to be warranted.
As for verifying of an IgE-mediated food allergy, different specific mensurations should be accomplished in order to include/exclude the suspected food(s). One protocol for meticulous interpretation −concerning the production of specific IgE-antibodies− is the accepted/endorsed prick-puncture skin-testing.
Of note, Skin-Prick-Tests (SPTs) are referred to as authentic predicting-value in cases where they become negative (over 95 %).
Methodically, Ventral surfaces of wistar rats were utilised for intra-dermal skin-testing with Crude Peanut Extract (CPE). So primarily, 5-min before the test, 100 µL of Evan's blue dye was administered into the tail-vein to aid visualising the wheal reaction.
Subsequently, 66 µL of the filter-sterilised CPE was injected intra-dermally into the already shaved abdominal skin. (Negative counterparts were placed, too).
A positive test-response was defined as a wheal-reaction emerging as a blue bump sizing diametrically, greater than 5 mm.
Predictably, abdominal aspects of the examined wistars, merely in positive group, revealed a wheal-reaction as a blue circle close to 1-cm in diameter, while recording −20-min subsequent to id peanut-challenge.
Putting together, although animal models carry actually, advantageous responsibilities in inspecting the food-allergy patho-mechanisms, and so forth, Nonetheless, a variety of validating researches remain still to be performed. On this concern, any required, efficacious and qualified instructions, as well as, reliable conducts might be accurately familiarised for imitating the complications of interest, and eventually, recruiting the recently obtained information in forthcoming human-subject experiments.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.